adapalene has been researched along with tazarotene in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 22 (68.75) | 29.6817 |
| 2010's | 6 (18.75) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Leyden, JJ | 2 |
| Chandraratna, RA; Nagpal, S | 1 |
| Kakita, L | 1 |
| Draelos, Z; Kakita, L; Leyden, J; Lowe, N | 1 |
| Bershad, S | 1 |
| Guenther, L; Lee, J; Loven, K; Poulin, YP; Solomon, BA; Webster, GF | 1 |
| Liao, DC | 1 |
| Baker, MD; Georgeian, K; Gilbert, R; Greenspan, A; Loesche, C; Poncet, M; Soto, P; Vendetti, N | 1 |
| Del Rosso, JQ | 2 |
| Noble, S; Scott, LJ; Waugh, J | 1 |
| Arsonnaud, S; Dosik, JS; Homer, K | 1 |
| Scheinfeld, N | 1 |
| Arsonnaud, S; Dosik, JS | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Date, A; Korting, HC; Mukherjee, S; Patravale, V; Roeder, A; Weindl, G | 1 |
| Arsonnaud, S; Soto, P; Thiboutot, D | 1 |
| Colón, LE; Gold, LS; Gottschalk, RW; Johnson, LA | 1 |
| Colón, LE; Gottschalk, RW; Johnson, LA; Pariser, D | 1 |
| Gollnick, H; Thielitz, A | 1 |
| Ghali, F; Kang, S; Leyden, J; Shalita, AR; Thiboutot, DM | 1 |
| Barnett, P; Del Rosso, J; Dhawan, S; Draelos, Z; Glaser, DA; Green, L; Grimes, P; Le Gall, N; Leyden, J; Shalita, A; Tanghetti, E; Webster, G | 1 |
| Dressler, C; Nast, A; Rosumeck, S | 1 |
| Bonati, LM; Silverberg, NB; Yeh, L | 1 |
| Ashique Rahman, MA; Hota, D; Maiti, R; Parida, S; Sirka, CS; Srinivasan, A | 1 |
| Chen, J; Fang, Z; Gao, L; Li, B; Li, Y; Shen, F; Wang, L; Wang, Y; Wu, M; Ye, J; Yuan, Z | 1 |
| Li, H; Li, L; Ma, P; Qian, K; Sun, J; Tao, L; Wang, C; Wei, J | 1 |
| Abdelmaksoud, A; Galadari, H; Goldust, M; Grabbe, S; Gupta, M; Karagaiah, P; Kassir, M; Katsambas, A; Lotti, T; Sonthalia, S; Wollina, U | 1 |
| Draelos, ZD | 1 |
14 review(s) available for adapalene and tazarotene
| Article | Year |
|---|---|
Topical treatment of acne vulgaris: retinoids and cutaneous irritation.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Gels; Humans; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Ointments; Retinoids; Tretinoin | 1998 |
Recent developments in receptor-selective retinoids.
Topics: Adapalene; Dermatologic Agents; Drug Design; Gene Expression; Humans; Naphthalenes; Nicotinic Acids; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Transcription Factors | 2000 |
Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Dermatologic Agents; Double-Blind Method; Gels; Keratolytic Agents; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2000 |
Developments in topical retinoid therapy for acne.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Drug Combinations; Humans; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Receptors, Retinoic Acid; Tretinoin; Vitamin A | 2001 |
Management of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Algorithms; Anti-Bacterial Agents; Benzoyl Peroxide; Contraceptives, Oral; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Dermatologic Agents; Dicarboxylic Acids; Humans; Isotretinoin; Macrolides; Naphthalenes; Nicotinic Acids; Salicylates; Tretinoin; United States | 2003 |
Topical retinoids in the management of acne: the best path to clear results.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Humans; Keratolytic Agents; Meta-Analysis as Topic; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Retinoids; Treatment Outcome; Tretinoin; United States | 2004 |
Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Dermatologic Agents; Drug Administration Schedule; Female; Gels; Humans; Male; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Retinoids; Severity of Illness Index; Time Factors; Treatment Outcome; Tretinoin; United States | 2004 |
Spotlight on adapalene in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Drug Administration Schedule; Gels; Humans; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2004 |
Schools of pharmacology: retinoid update.
Topics: Adapalene; Humans; Isotretinoin; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Retinoids; Skin Diseases; Tretinoin | 2006 |
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.
Topics: Adapalene; Dermatologic Agents; Dermis; Epidermis; Humans; Naphthalenes; Nicotinic Acids; Retinaldehyde; Retinoids; Skin Aging; Treatment Outcome; Tretinoin; Vitamin A Deficiency | 2006 |
Topical retinoids in acne vulgaris: update on efficacy and safety.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Isotretinoin; Naphthalenes; Nicotinic Acids; Retinoids; Safety; Tretinoin | 2008 |
Changing the face of acne therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Age Factors; Clinical Protocols; Dermatologic Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Naphthalenes; Nicotinic Acids; Nonprescription Drugs; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retinoids; Treatment Outcome | 2009 |
How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Dermatologic Agents; Gels; Humans; Isotretinoin; Nicotinic Acids; Treatment Outcome | 2016 |
Selective RAR agonists for acne vulgaris: A narrative review.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Humans; Nicotinic Acids; Randomized Controlled Trials as Topic; Receptors, Retinoic Acid; Retinoids; Treatment Outcome; Tretinoin | 2020 |
11 trial(s) available for adapalene and tazarotene
| Article | Year |
|---|---|
Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Nicotinic Acids; Treatment Outcome | 2001 |
A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Cost-Benefit Analysis; Dermatologic Agents; Double-Blind Method; Facial Dermatoses; Female; Gels; Humans; Male; Naphthalenes; Nicotinic Acids; Ontario; Pennsylvania; Severity of Illness Index; Tennessee; Treatment Outcome | 2002 |
Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
Topics: Adapalene; Adult; Aged; Dermatologic Agents; Double-Blind Method; Drug Interactions; Erythema; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Probability; Sensitivity and Specificity; Skin Irritancy Tests; Tretinoin | 2003 |
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
Topics: Acne Vulgaris; Adapalene; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Ointments; Retinoids; Skin Irritancy Tests | 2005 |
Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.
Topics: Adapalene; Administration, Cutaneous; Adult; Aged; Dermatitis, Irritant; Dermatologic Agents; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Ointments; Patient Satisfaction; Pruritus; Self Administration; Skin Physiological Phenomena; Skin Pigmentation; Treatment Outcome | 2007 |
Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythema; Female; Gels; Humans; Male; Naphthalenes; Nicotinic Acids; Skin; Surveys and Questionnaires | 2008 |
Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythema; Female; Gels; Humans; Male; Naphthalenes; Nicotinic Acids; Retinoids; Skin; Surveys and Questionnaires | 2008 |
Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythema; Female; Humans; Male; Naphthalenes; Nicotinic Acids; Skin | 2008 |
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Dermatologic Agents; Female; Gels; Humans; Hyperpigmentation; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Severity of Illness Index; Single-Blind Method; Young Adult | 2010 |
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Nicotinic Acids; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2017 |
Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies.
Topics: Acne Vulgaris; Adapalene; Adult; Dermatologic Agents; Double-Blind Method; Emollients; Humans; Naphthalenes; Retinoids; Treatment Outcome | 2023 |
7 other study(ies) available for adapalene and tazarotene
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction.
Topics: Acne Vulgaris; Adapalene; Adolescent; Child; Dermatologic Agents; Drug Therapy, Combination; Humans; Naphthalenes; Nicotinic Acids; Retinoids | 2008 |
Topical retinoids for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Humans; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2016 |
Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen.
Topics: Acitretin; Adapalene; Antiviral Agents; Cell Line; Cell Survival; Dermatologic Agents; Drug Repositioning; Drug Synergism; Gene Expression; Guanine; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; High-Throughput Screening Assays; Host-Pathogen Interactions; Humans; Keratolytic Agents; Nicotinic Acids; Receptors, Retinoic Acid; Transcription, Genetic; Tretinoin; Virus Replication | 2018 |
The third-generation retinoid adapalene triggered DNA damage to induce S-phase arrest in HaCat cells.
Topics: Adapalene; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Proliferation; DNA Damage; DNA Repair; G1 Phase; HaCaT Cells; Humans; Nicotinic Acids; Retinoids; S Phase; Up-Regulation | 2020 |